Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Increased regulatory T cell activity may lead to better outcomes in acute diffuse and total alopecia.

A bull with a gene mutation was asymptomatic, synthetic retinoids cause hair loss, and new therapeutic targets were identified for skin diseases.

Immunosuppressive therapy helps manage autoimmune diseases but carries risks like infection and potential for malignancy.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Collagen VII helps skin heal and stay strong, sirolimus may lower skin cancer risk in kidney transplant patients, high-molecular-mass hyaluronan helps naked mole rats resist cancer, dermal γδ T cells aid in hair growth in rodents, and overexpression of IL-33 in mouse skin causes itchiness, offering a model for studying allergic inflammation treatments.

Methotrexate, resveratrol, and curcumin may help treat alopecia areata by targeting immune cells.

Certain gene variations are linked to alopecia areata.

The document explains how the immune system reacts to organ transplants and the treatments used to prevent rejection.

Fetal skin has unique immune cells different from adult skin.

New therapies aim to improve long-term hair regrowth in alopecia areata by targeting immune responses.

Hair growth phase in mice weakens certain immune responses.

Alopecia areata involves immune system changes, especially in severe cases, with potential new treatment targets identified.

NCBP3, SDHA, and PTPRA are the best genes for normalizing goat skin experiments.

Researchers found certain genes are overactive and others are underactive in men with early balding, which could help create new treatments.

Understanding and manipulating epigenetic changes can potentially lead to human organ regeneration therapies, but more research is needed to improve these methods and minimize risks.

lncRNAs are important for understanding and treating skin diseases.

miR-5110 affects alpaca pigmentation by altering specific gene expressions.

A new mouse model for vitiligo helps study immune responses and potential treatments.

Keratin gene regulation is similar across mammals, affecting hair follicle differentiation.

CDKN2AIP gene is less active in nevus sebaceous, affecting related RNA networks.

Male-to-female skin grafts in mice are rejected due to sex-linked antigens.

Innate lymphoid cells help us understand and manage allergic diseases better.

Removing UBE2N from skin cells causes inflammation and immune response, which can be lessened with specific inhibitors.

Higher TGF-β signaling may increase skin cancer risk in organ transplant recipients.

Targeting CD200 could be a new treatment for rheumatoid arthritis.

Systemic immunotherapies are used for immune-related hair loss but not usually for genetic hair loss, unless the patient has both conditions.

The BMP/Smads pathway and Id2 gene control hair follicle stem cells, affecting their rest and growth phases.

TLR3 activation helps improve skin and hair follicle healing in mice.

The study identified key genes and pathways linked to hair disorders, aiding precision medicine.

Immune cells might contribute to hair loss caused by a specific mutation.